From Donor to Recipient: Current Questions Relating to Humoral Alloimmunization
Alloimmunization is an undesirable iatrogenic effect of transfusion and transplantation. In fact, recipients can be considered as responders or not responders, in a continuum from tolerance, including organ transplantation and transfusion, to polyimmunized and refractory patients. New models and lar...
Main Authors: | Antoine Prigent, Nicolas Maillard, Léna Absi, Chaker Aloui, Fabrice Cognasse, Sandrine Laradi, Christophe Mariat, Olivier Garraud |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-02-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4468/3/1/130 |
Similar Items
-
Alloimmunization in Transfusion Dependent Thalassaemic Patients.
by: Saad H. Ahmed, et al.
Published: (2010-04-01) -
Red blood cell alloimmunization in Iran: A Comprehensive review of the literature
by: Maryam Sadat Hosseini, et al.
Published: (2020-01-01) -
Identification of platelet refractoriness in oncohematologic patients
by: Aline Aparecida Ferreira, et al.
Published: (2011-01-01) -
Spectrum of alloimmunization among multitransfused beta-thalassemia major patients
by: Usman Waheed, et al.
Published: (2019-01-01) -
Red cell alloimmunization in multi-transfused, oncology patients: Risks and management
by: Sadhana Mangwana, et al.
Published: (2019-01-01)